Can a child with Hirschsprung disease who has undergone corrective surgery and is otherwise healthy receive the measles‑rubella (MMR) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 12, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Yes, a child with Hirschsprung disease who has undergone corrective surgery and is otherwise healthy should receive the measles-rubella (MMR) vaccine on the standard schedule.

Hirschsprung disease itself is not a contraindication to MMR vaccination, and children who have recovered from corrective surgery without ongoing immunosuppression should follow the routine immunization schedule. 1

Key Contraindications to MMR Vaccine

The only true contraindications to MMR vaccination are: 1, 2

  • Severe allergic reaction (anaphylaxis) to a prior vaccine dose or vaccine component
  • Severe immunosuppression (≥2 mg/kg/day prednisone equivalent for ≥14 days, chemotherapy, or biologic agents) 3
  • Pregnancy 3, 2
  • Recent administration of immune globulin products 1

Hirschsprung disease does not appear on any list of contraindications for MMR vaccination. 3, 1

When to Vaccinate

  • Minor illnesses, including diarrhea and gastrointestinal symptoms, are NOT contraindications to vaccination and should not delay immunization. 1

  • Vaccination should only be deferred for moderate or severe febrile illness or severe immunosuppression—not for the underlying diagnosis of Hirschsprung disease. 1

  • If the child appears healthy or has only minor symptoms following surgery, vaccination should proceed according to the standard schedule: first dose at 12-15 months and second dose at 4-6 years. 1, 4

Clinical Decision-Making Algorithm

  1. Assess current immunosuppression status: Is the child on high-dose corticosteroids (≥2 mg/kg/day for ≥14 days), chemotherapy, or biologic agents? 3

    • If YES → defer MMR until at least 3 months after stopping immunosuppressive therapy 3
    • If NO → proceed with vaccination
  2. Assess current clinical status: Does the child have moderate-to-severe febrile illness today? 1

    • If YES → defer until recovery
    • If NO or only minor symptoms → vaccinate today
  3. Verify no other true contraindications (anaphylaxis history, pregnancy, recent immune globulin) 1, 2

Important Caveats

  • Post-surgical status alone does not constitute immunosuppression. Children who have recovered from Hirschsprung surgery without ongoing immunosuppressive medications are considered immunocompetent. 1

  • Do not postpone vaccination for routine medical conditions or minor gastrointestinal symptoms, as this creates unnecessary delays in protection and missed opportunities. 1

  • The protective benefits of MMR vaccination far outweigh theoretical concerns in children with stable surgical conditions like corrected Hirschsprung disease. 1

  • The evidence base for MMR safety is robust, with serious adverse events occurring in only 0.05% of recipients and vaccine-related infections in 0.2%. 3

Strength of Evidence

The recommendation to vaccinate is based on high-quality evidence showing MMR vaccine effectiveness of at least 95% for measles and 92% for preventing secondary household cases, with moderate certainty of evidence for safety in healthy children. 3, 5 The Canadian Association of Gastroenterology provides strong recommendations (100% consensus) that children with gastrointestinal conditions who are not on immunosuppressive therapy should receive MMR vaccine. 3

References

Guideline

MR Vaccine Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Post-Exposure Prophylaxis for Measles

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2013

Research

Vaccines for measles, mumps and rubella in children.

The Cochrane database of systematic reviews, 2012

Related Questions

What are the symptoms and treatment options for Measles, Mumps, and Rubella (MMR)?
Can a pediatric patient with cough, cold, fever, and loose stools receive immunization with the measles, mumps, and rubella (MMR) vaccine?
At what age can the MMRV (Measles, Mumps, Rubella, and Varicella) vaccine be given to a 9-month-old infant?
Does a person born in 1962 need the measles, mumps, and rubella (MMR) vaccine?
Can a 6-month-old infant receive the Measles, Mumps, and Rubella (MMR) vaccine?
In a child with generalized lymphadenopathy, hepatomegaly, low‑grade fever, and recent weight loss, what is the most appropriate initial diagnostic test?
What is the recommended management of hyponatremia, considering acute versus chronic onset, symptom severity, and volume status?
What is the recommended management for right horizontal canal benign paroxysmal positional vertigo in a patient without red‑flag features?
What is the appropriate prescription for a patient presenting to the outpatient department with allergic dermatitis?
What is the recommended acute management for an adult with moderate to severe traumatic brain injury, including airway, breathing, circulation, cervical spine protection, Glasgow Coma Scale assessment, indications for intubation, non‑contrast head CT criteria, surgical evacuation of intracranial hemorrhage, intracranial pressure control measures, seizure prophylaxis, deep‑venous thrombosis prophylaxis, and hemodynamic targets?
What is the most common cause of maternal death worldwide?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.